{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:57:40Z","timestamp":1793383060709,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["115056"],"award-info":[{"award-number":["115056"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","award":["2018-19 MSc Project \u2013 LSHTM Trust Funds"],"award-info":[{"award-number":["2018-19 MSc Project \u2013 LSHTM Trust Funds"]}],"id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In 2019, the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      malaria vaccine was introduced on a pilot basis in six regions of Ghana by the Ministry of Health\/Ghana Health Service as part of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP). This is the first time a malaria vaccination programme has been implemented in any country. This paper describes the challenges faced, and lessons learned, during the planning and early implementation of the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      vaccine in three out of the six regions that implemented the programme in Ghana.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty-one in-depth interviews were conducted with regional and district health service managers and frontline health workers three months after the start of MVIP in May 2019. Data were coded using NVivo software version 12 and a coding framework was developed to support thematic analysis to identify the challenges and lessons learned during the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      implementation pilot, which were also categorized into the Consolidated Framework for Implementation Research (CFIR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants reported challenges related to the characteristics of the intervention, such as issues with the vaccine schedule and eligibility criteria, and challenges related to how it was implemented as a pilot programme. Additionally, major challenges were faced due to the spread of rumours leading to vaccine refusals; thus, the outer setting of the CFIR was adapted to accommodate rumours within the community context. Health service managers and frontline health workers also experienced challenges with the process of implementing RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      , including inadequate sensitization and training, as well as issues with the timeline. They also experienced challenges associated with the features of the systems within which the vaccine was being implemented, including inadequate resources for cold-chain at the health facility level and transportation at the district and health facility levels. This study identified the need for a longer, more intensive and sustained delivery of contextually-appropriate sensitization prior to implementation of a programme such as MVIP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study identified 12 main challenges and lessons learned by health service managers and health workers during the planning and early implementation phases of the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      pilot introduction in Ghana. These findings are highly relevant to the likely scale-up of RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      within Ghana and possible implementation in other African countries, as well as to other future introductions of novel vaccines.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04168-9","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T06:24:55Z","timestamp":1652336695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Challenges and lessons learned during the planning and early implementation of the RTS,S\/AS01E malaria vaccine in three regions of Ghana: a qualitative study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-4042","authenticated-orcid":false,"given":"Jane","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Agbokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"4168_CR1","first-page":"2020","volume-title":"20 years of global progress and challenges","author":"WHO. World malaria report","year":"2020","unstructured":"WHO. World malaria report. 20 years of global progress and challenges. Geneva: World Health Organization; 2020. p. 2020."},{"key":"4168_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTSS Clinical Trials Partnership","year":"2015","unstructured":"RTSS Clinical Trials Partnership. Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31\u201345.","journal-title":"Lancet"},{"key":"4168_CR3","first-page":"33","volume":"4","author":"WHO","year":"2016","unstructured":"WHO. Malaria vaccine: WHO position paper\u2014January 2016. Wkly Epidemiol Record. 2016;4:33\u201351.","journal-title":"Wkly Epidemiol Record."},{"key":"4168_CR4","unstructured":"WHO. Malaria: The malaria vaccine implementation programme (MVIP). Geneva, World Health Organization, 2020. https:\/\/www.who.int\/news-room\/q-a-detail\/malaria-vaccine-implementation-programme. Accessed 15 Aug 2021."},{"key":"4168_CR5","unstructured":"WHO. Malaria vaccine pilot launched in Ghana. Geneva, World Health Organization, 2019. https:\/\/www.afro.who.int\/news\/malaria-vaccine-pilot-launched-ghana. Accessed 15 Aug 2021."},{"key":"4168_CR6","first-page":"61","volume":"9","author":"WHO","year":"2022","unstructured":"WHO. Malaria vaccine: WHO position paper\u2014March 2022. Wkly Epidemiol Record. 2022;9:61\u201380.","journal-title":"Wkly Epidemiol Record."},{"key":"4168_CR7","unstructured":"FDA Ghana, Ghana Health Service. Frequently Asked Questions, RTS,S\/AS01 Malaria Vaccine (Mosquirix). 2019. https:\/\/fdaghana.gov.gh\/images\/stories\/pdfs\/Frequently\/FAQs RTSS malaria vaccine-FINAL.pdf. Accessed 15 Aug 2021."},{"key":"4168_CR8","unstructured":"WHO, United Nations Children\u2019s Fund. WHO vaccine-preventable diseases: monitoring system. 2020 Global Summary. Ghana Country Profile. Geneva, World Health Organization, 2020. https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=GHA. Accessed 15 Aug 2021."},{"key":"4168_CR9","unstructured":"Ghana Statistical Service. 2010 Population and housing census: Final results. Accra, 2012."},{"key":"4168_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1475-2875-9-314","volume":"9","author":"D Dery","year":"2010","unstructured":"Dery D, Brown C, Asante K, Adams M, Dosoo D, Amenga-Etego S, et al. Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana. Malar J. 2010;9:314.","journal-title":"Malar J"},{"key":"4168_CR11","unstructured":"Ghana Statistical Service (GSS) and ICF. Ghana Malaria Indicator Survey 2019. Accra, Ghana, and Rockville, Maryland, USA: GSS and ICF. 2020."},{"key":"4168_CR12","unstructured":"Consortium to Evaluate Mosquirix in Ghana. An evaluation of the cluster-randomised pilot implementation of RTS,S\/AS01 through routine health systems in Ghana. Version 1.6 28 January 2019 (Unpublished protocol)."},{"key":"4168_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"N Gale","year":"2013","unstructured":"Gale N, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.","journal-title":"BMC Med Res Methodol"},{"key":"4168_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"4168_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/21645515.2019.1654798","volume":"16","author":"AA Adamu","year":"2020","unstructured":"Adamu AA, Uthman OA, Gadanya MA, Wiysonge CS. Using the consolidated framework for implementation research (CFIR) to assess the implementation context of a quality improvement program to reduce missed opportunities for vaccination in Kano, Nigeria: a mixed methods study. Hum Vaccin Immunother. 2020;16:465\u201375.","journal-title":"Hum Vaccin Immunother"},{"key":"4168_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13012-018-0846-2","volume":"13","author":"C Soi","year":"2018","unstructured":"Soi C, Gimbel S, Chilundo B, Muchanga V, Matsinhe L, Sherr K. Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR). Implement Sci. 2018;13:151.","journal-title":"Implement Sci"},{"key":"4168_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12992-017-0310-0","volume":"13","author":"E Dansereau","year":"2017","unstructured":"Dansereau E, Miangotar Y, Squires E, Mimche H, el Bcheraoui C. Challenges to implementing Gavi\u2019s health system strengthening support in Chad and Cameroon: results from a mixed-methods evaluation. Glob Health. 2017;13:83.","journal-title":"Glob Health"},{"key":"4168_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13012-020-0977-0","volume":"15","author":"AR Means","year":"2020","unstructured":"Means AR, Kemp CG, Gwayi-Chore MC, Gimbel S, Soi C, Sherr K, et al. Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low- And middle-income countries: a systematic review. Implement Sci. 2020;15:17.","journal-title":"Implement Sci"},{"key":"4168_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89:1245\u201351.","journal-title":"Acad Med"},{"key":"4168_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s12889-017-4618-8","volume":"17","author":"PE Kummervold","year":"2017","unstructured":"Kummervold PE, Schulz WS, Smout E, Fernandez-Luque L, Larson HJ. Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news. BMC Public Health. 2017;17:642.","journal-title":"BMC Public Health"},{"key":"4168_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/vaccines9080814","volume":"9","author":"T Acheampong","year":"2021","unstructured":"Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine hesitancy in sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive covid-19 vaccines in Ghana. Vaccines. 2021;9:814.","journal-title":"Vaccines"},{"key":"4168_CR22","unstructured":"Brackstone K, Atengble K, Head M, Akinocho H, Osei K, Nuamah K, et al. Examining drivers of COVID-19 vaccine hesitancy in Ghana. MedRxiv. 2022."},{"key":"4168_CR23","volume-title":"Lessons learned from vaccine introduction experiences. Opportunities for inactivated poliovirus vaccine (IPV)","author":"WHO","year":"2014","unstructured":"WHO. Lessons learned from vaccine introduction experiences. Opportunities for inactivated poliovirus vaccine (IPV). Geneva: World Health Organization; 2014."},{"key":"4168_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2017.06.003","volume":"4","author":"N Howard","year":"2017","unstructured":"Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, et al. What works for human papillomavirus vaccine introduction in low and middle-income countries? Papillomavirus Res. 2017;4:22\u20135.","journal-title":"Papillomavirus Res"},{"issue":"Suppl 3","key":"4168_CR25","doi-asserted-by":"publisher","first-page":"C66","DOI":"10.1016\/j.vaccine.2012.06.033","volume":"30","author":"A Baleta","year":"2012","unstructured":"Baleta A, van den Heever J, Burnett R. Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa\u2014Successes and challenges. Vaccine. 2012;30(Suppl 3):C66-71.","journal-title":"Vaccine"},{"key":"4168_CR26","unstructured":"Government of Ghana. Comprehensive Multi-year Plan for Immunizations (2015\u20132019). Accra, 2014."},{"key":"4168_CR27","unstructured":"WHO. Ghana MVIP Monthly Data Bulletin, June 2019. Accra, Ghana, 2019."},{"key":"4168_CR28","volume-title":"Meeting of the strategic advisory group of experts on immunization, 4\u20138 October 2021","author":"WHO","year":"2021","unstructured":"WHO. Meeting of the strategic advisory group of experts on immunization, 4\u20138 October 2021. Geneva: World Health Organization; 2021."},{"key":"4168_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.29245\/2578-3009\/2018\/si.1117","volume":"2","author":"B Masresha","year":"2018","unstructured":"Masresha B, Luce R, Okeibunor J, Shibeshi M, Kamadjeu R, Fall A. Introduction of the second dose of measles containing vaccine in the childhood vaccination programs within the WHO Africa region\u2014lessons learnt. J Immunol Sci. 2018;2:113\u201321.","journal-title":"J Immunol Sci"},{"key":"4168_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.11604\/pamj.supp.2017.27.3.12182","volume":"27","author":"M Nyaku","year":"2017","unstructured":"Nyaku M, Wardle M, vanden Eng J, Ametewee L, Bonsu G, LarbiOpare JK, et al. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach. Pan Afr Med J. 2017;27:4.","journal-title":"Pan Afr Med J"},{"key":"4168_CR31","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","volume":"385","author":"D Chandramohan","year":"2021","unstructured":"Chandramohan D, Zongo I, Sagara I, Cairns M, Yerbanga RS, Diarra M, et al. Seasonal vaccination with the RTS, S\/AS01E malaria vaccine with or without seasonal malaria chemoprevention. N Engl J Med. 2021;385:1005\u201317.","journal-title":"N Engl J Med"},{"key":"4168_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/14760584.2019.1574224","volume":"18","author":"A Guignard","year":"2019","unstructured":"Guignard A, Praet N, Jusot V, Bakker M, Baril L. Introducing new vaccines in low- and middle-income countries: challenges and approaches. Expert Rev Vaccines. 2019;18:119\u201331.","journal-title":"Expert Rev Vaccines"},{"key":"4168_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227974","volume":"15","author":"A Heerdegen","year":"2020","unstructured":"Heerdegen A, Aikins M, Amon S, Agyemang S, Wyss K. Managerial capacity among district health managers and its association with district performance: a comparative descriptive study of six districts in the Eastern Region of Ghana. PLoS ONE. 2020;15: e0227974.","journal-title":"PLoS ONE"},{"key":"4168_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fpubh.2020.00270","volume":"8","author":"A Heerdegen","year":"2020","unstructured":"Heerdegen A, Gerold J, Amon S, Agyemang S, Aikins M, Wyss K. How does district health management emerge within a complex health system? Insights for capacity strengthening in Ghana. Front Public Health. 2020;8:270.","journal-title":"Front Public Health"},{"key":"4168_CR35","unstructured":"USAID. Impact of new vaccine introduction on developing country immunization programs\u202f: a review of the grey literature. 2012; January:1\u201330."},{"key":"4168_CR36","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.180406","volume":"16","author":"C Escoffery","year":"2019","unstructured":"Escoffery C, Riehman K, Watson L, Priess AS, Borne MF, Halpin SN, et al. Facilitators and barriers to the implementation of the HPV VACs (vaccinate adolescents against cancers) program: a consolidated framework for implementation research analysis. Prev Chronic Dis. 2019;16: 180406.","journal-title":"Prev Chronic Dis"},{"key":"4168_CR37","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.socscimed.2009.01.038","volume":"68","author":"A Kaler","year":"2009","unstructured":"Kaler A. Health interventions and the persistence of rumour: the circulation of sterility stories in African public health campaigns. Soc Sci Med. 2009;68:1711\u20139.","journal-title":"Soc Sci Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04168-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T06:25:23Z","timestamp":1652336723000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04168-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4168"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04168-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the study was obtained from the Kintampo Health Research Centre Institutional Ethics Committee and the ethics committee of the London School of Hygiene and Tropical Medicine. Written informed consent was obtained from all the study participants prior to their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Kintampo Health Research Centre, Research and Development Division of Ghana Health Service received funding from WHO to evaluate MVIP.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}